The ongoing COVID-19 pandemic has created an unprecedented need for rapid diagnostic
testing. The World Health Organization (WHO) recommends a standard assay that includes …

Influenza A virus buds through the apical plasma membrane, forming enveloped virus particles
that can take the shape of pleomorphic spheres or vastly elongated filaments. For either …

With the COVID‐19 pandemic caused by SARS‐CoV‐2 now in its second year, there remains
an urgent need for diagnostic testing that can identify infected individuals, particularly …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified
coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19)…

The viral RNA (vRNA) genome of influenza A virus is replicated in the nucleus, exported to
the cytoplasm as ribonucleoproteins (RNPs), and trafficked to the plasma membrane through …

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants pose a
challenge to controlling the COVID-19 pandemic. Previous studies indicate that clinical samples …

There is an urgent need for antiviral agents that treat severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. We screened a library of 1900 clinically safe drugs …

Neutralizing antibodies (NAbs) are effective in treating COVID-19, but the mechanism of
immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary
manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its …

The mechanism of membrane scission during influenza A virus budding has been the
subject of controversy. We confirm that influenza M1 binds VPS28, a subunit of the ESCRT-1 …